Literature DB >> 12111440

The insulin gene VNTR polymorphism in Alzheimer's disease: results of a pilot study.

M Majores1, Heiki Kölsch, M Bagli, U Ptok, M Kockler, K Becker, M L Rao, W Maier, R Heun.   

Abstract

Insulin (INS) and insulin-like growth factors include different polypeptides involved in growth and development. Possibly they play a role in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease (AD). A variable number of tandem repeats (VNTR) polymorphism at the human INS 5'-flanking region consisting of three distinct allele classes has been shown to influence the tissue-specific expression of INS and the insulin-like growth factor 2 (IGF-2). Since alterations in the expression of INS or IGF-2 might be relevant in AD, we investigated the association between the INS VNTR polymorphism and the risk for AD. We found no association between the INS VNTR genotype and the risk for AD (p = 0.873). However, survival analysis revealed that class III homozygotes of the INS VNTR polymorphism had an earlier initial onset in patients suffering from early AD (p = 0.002). Our preliminary results suggest, that genetically determined alterations of the INS/IGF-2 metabolism might modify the course of AD. Further studies are warranted to confirm these data in larger study samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111440     DOI: 10.1007/s007020200086

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  4 in total

1.  Interaction of insulin and PPAR-α genes in Alzheimer's disease: the Epistasis Project.

Authors:  Heike Kölsch; Donald J Lehmann; Carla A Ibrahim-Verbaas; Onofre Combarros; Cornelia M van Duijn; Naomi Hammond; Olivia Belbin; Mario Cortina-Borja; Michael G Lehmann; Yurii S Aulchenko; Maaike Schuur; Monique Breteler; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Ignacio Mateo; Wolfgang Maier; Kevin Morgan; Donald R Warden; A David Smith; Reinhard Heun
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

2.  Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition.

Authors:  R O Domínguez; E R Marschoff; E M Guareschi; M G Repetto; A L Famulari; M A Pagano; J A Serra
Journal:  J Neural Transm (Vienna)       Date:  2007-08-30       Impact factor: 3.575

3.  Revelation of Pivotal Genes Pertinent to Alzheimer's Pathogenesis: A Methodical Evaluation of 32 GEO Datasets.

Authors:  Hema Sree Gns; Saraswathy Ganesan Rajalekshmi; Raghunadha R Burri
Journal:  J Mol Neurosci       Date:  2021-10-19       Impact factor: 2.866

Review 4.  Searching the Dark Genome for Alzheimer's Disease Risk Variants.

Authors:  Rachel Raybould; Rebecca Sims
Journal:  Brain Sci       Date:  2021-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.